Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan P Cerliani

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Stem Cells (Dayton, Ohio)|November 20, 2014
Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/Bim pathwayRicardo Gargini, Juan P Cerliani, Maribel Escoll, et al.
Handbook of Experimental Pharmacology|April 14, 2017
Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic TherapiesDiego O Croci, Santiago P Mendez-Huergo, Juan P Cerliani, et al.
Trends in Biochemical Sciences|December 18, 2016
Translating the 'Sugar Code' into Immune and Vascular Signaling ProgramsJuan P Cerliani, Ada G Blidner, Marta A Toscano, et al.
Glycobiology|August 14, 2014
Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatmentDiego O Croci, Juan P Cerliani, Nicolas A Pinto, et al.
International Immunopharmacology|February 8, 2011
Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applicationsIván D Mascanfroni, Juan P Cerliani, Sebastián Dergan-Dylon, et al.
Journal of Clinical Immunology|December 25, 2010
Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunityJuan P Cerliani, Sean R Stowell, Iván D Mascanfroni, et al.
Oncotarget|May 12, 2016
Galectin-1 is essential for efficient liver regeneration following hepatectomyTamara Potikha, Ezra Ella, Juan P Cerliani, et al.
Medicina|December 18, 2010
Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasiaJuan P Cerliani, Sebastián Giulianelli, Ana Sahores, et al.
Biochemistry|August 19, 2011
When galectins recognize glycans: from biochemistry to physiology and back againSantiago Di Lella, Victoria Sundblad, Juan P Cerliani, et al.
Cancer Research|April 6, 2011
Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancerJuan P Cerliani, Tomás Guillardoy, Sebastián Giulianelli, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Stem Cells (Dayton, Ohio)|November 20, 2014
Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/Bim pathwayRicardo Gargini, Juan P Cerliani, Maribel Escoll, et al.
Handbook of Experimental Pharmacology|April 14, 2017
Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic TherapiesDiego O Croci, Santiago P Mendez-Huergo, Juan P Cerliani, et al.
Trends in Biochemical Sciences|December 18, 2016
Translating the 'Sugar Code' into Immune and Vascular Signaling ProgramsJuan P Cerliani, Ada G Blidner, Marta A Toscano, et al.
Glycobiology|August 14, 2014
Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatmentDiego O Croci, Juan P Cerliani, Nicolas A Pinto, et al.
International Immunopharmacology|February 8, 2011
Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applicationsIván D Mascanfroni, Juan P Cerliani, Sebastián Dergan-Dylon, et al.
Journal of Clinical Immunology|December 25, 2010
Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunityJuan P Cerliani, Sean R Stowell, Iván D Mascanfroni, et al.
Oncotarget|May 12, 2016
Galectin-1 is essential for efficient liver regeneration following hepatectomyTamara Potikha, Ezra Ella, Juan P Cerliani, et al.
Medicina|December 18, 2010
Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasiaJuan P Cerliani, Sebastián Giulianelli, Ana Sahores, et al.
Biochemistry|August 19, 2011
When galectins recognize glycans: from biochemistry to physiology and back againSantiago Di Lella, Victoria Sundblad, Juan P Cerliani, et al.
Cancer Research|April 6, 2011
Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancerJuan P Cerliani, Tomás Guillardoy, Sebastián Giulianelli, et al.
Pageof 3